Requires every individual or group health insurance contract effective on or after January 1, 2026, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Impact
The bill's impact on state laws includes expanding insurance mandates for contraceptive coverage, thereby potentially increasing enrollment in plans that include such services and improving public health outcomes related to reproductive health. It seeks to eliminate cost barriers that have traditionally hindered access to contraceptive services by requiring plans to provide them without deductibles or other forms of cost-sharing. This move has the potential to lead to increased contraceptive usage, further promoting family planning and informed healthcare choices among insured individuals.
Summary
S0268 is a proposed act that aims to amend insurance regulations in relation to contraceptive methods and services. Specifically, the bill requires that every individual or group health insurance contract effective on or after January 1, 2026, is mandated to provide coverage for all FDA-approved contraceptive drugs and devices, voluntary sterilization procedures, alongside counseling and follow-up services. This legislation is designed to ensure that individuals and their spouses and dependents have access to comprehensive contraceptive care without copayments or additional charges, aiming to increase accessibility and affordability of reproductive healthcare.
Sentiment
The sentiment surrounding S0268 varies significantly among stakeholders. Proponents, including various health advocacy groups, view it positively, emphasizing the importance of accessible contraceptive coverage as a critical component of healthcare. They argue that the bill is a step forward in ensuring health equity. Conversely, opponents, particularly from certain religious groups, express concerns regarding mandates that may conflict with their beliefs regarding contraception, fearing that such regulations could undermine their ability to make choices aligned with their values.
Contention
Notable points of contention revolve around the inclusion of voluntary sterilization in the required coverage and the implications for religious employers who may wish to exclude contraceptive services based on their doctrinal beliefs. The bill allows for some exemptions, but the conditions under which these apply are a source of debate, as opponents argue that the legislation could lead to unintended consequences and a decrease in religious freedoms regarding healthcare decisions.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Requires that any insurance contract issued, amended or renewed on or after January 1, 2025, that provides hospital, medical or surgical coverage shall provide coverage for medically necessary treatment of mental health or substance use disorders.
Adds a new section which sets forth conditions for pharmacists to prescribe tobacco cessation/drug therapies, programs approved by the state board of pharmacy. The cessation therapies would be covered by all health insurance carriers on or after 1/1/25.
Adds a new section which sets forth conditions for pharmacists to prescribe tobacco cessation/drug therapies, programs approved by the state board of pharmacy. The cessation therapies would be covered by all health insurance carriers on or after 1/1/25.
Mandates all health insurance contracts from January 1, 2026, to cover FDA-approved contraceptives, sterilization, contraception counseling, follow-up services, and a twelve-month supply for Medicaid recipients.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.